Endogenous retroviruses up-regulated in prostate cancer

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/70 (2006.01) A61K 39/00 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01) C07K 14/00 (2006.01) C07K 14/15 (2006.01) C07K 16/00 (2006.01) C12N 7/00 (2006.01) C12Q 1/68 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2430379

Human endogenous retroviruses of the HML-2 family show up-regulated expression in prostate tumors. This finding can be used in prostate cancer screening, diagnosis and therapy.

L'invention se rapporte à des rétrovirus endogènes humains de la famille des HML-2, dont l'expression est régulée positivement dans des tumeurs de la prostate. Cette invention peut être utilisée pour le dépistage, l'établissement du diagnostic et le traitement du cancer de la prostate.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Endogenous retroviruses up-regulated in prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Endogenous retroviruses up-regulated in prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endogenous retroviruses up-regulated in prostate cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1490305

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.